NCT01582945View on ClinicalTrials.gov

Ketamine Infusion for Treatment-resistant Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

Ketamine IV 0.5mg/kg infusion twice a week for 3 weeks as augmentation of ongoing antidepressant regimen

Trial Locations (1)

02114

Depression Clinical and Research Program - MGH, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01582945 - Ketamine Infusion for Treatment-resistant Major Depressive Disorder | Biotech Hunter | Biotech Hunter